{"id":20837,"date":"2023-02-01T08:39:50","date_gmt":"2023-02-01T13:39:50","guid":{"rendered":"https:\/\/medicarereport.org\/?p=20837"},"modified":"2023-02-01T08:39:50","modified_gmt":"2023-02-01T13:39:50","slug":"abbvies-blockbuster-drug-humira-finally-loses-its-20-year-200-billion-monopoly","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=20837","title":{"rendered":"AbbVie&#8217;s blockbuster drug Humira finally loses its 20-year, $200 billion monopoly"},"content":{"rendered":"\n<p>(Leslie Walker and Dan Gorenstein for NPR)<\/p>\n\n\n\n<p>After 20 years and $200 billion in revenue, Humira \u2014 an injectable treatment for rheumatoid arthritis and several other autoimmune conditions \u2014 has lost its monopoly. Early Tuesday morning, California-based biotech firm Amgen released Amjevita, the first close copy of the best selling drug of all time. At least seven more Humira copycats, known as biosimilars, are expected to debut later this year.  Continue reading <a href=\"https:\/\/www.npr.org\/sections\/health-shots\/2023\/01\/31\/1152513058\/abbvies-blockbuster-drug-humira-finally-loses-its-20-year-200-billion-monopoly\" data-type=\"URL\" data-id=\"https:\/\/www.npr.org\/sections\/health-shots\/2023\/01\/31\/1152513058\/abbvies-blockbuster-drug-humira-finally-loses-its-20-year-200-billion-monopoly\">here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"54\" class=\"wp-image-3902\" style=\"width: 150px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png 152w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo-150x55.png 150w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>&nbsp;The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Leslie Walker and Dan Gorenstein for NPR) After 20 years and $200 billion in revenue, Humira \u2014 an injectable treatment<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,21,15],"tags":[428,76,429],"class_list":["post-20837","post","type-post","status-publish","format-standard","hentry","category-fda","category-health-care-finance","category-part-dprescription-drugs","tag-biosimilars-drugs","tag-fda","tag-generic-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20837"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20837\/revisions"}],"predecessor-version":[{"id":20838,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20837\/revisions\/20838"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}